LY255582

LY255582 is a centrally active, non-selective opioid receptor antagonist with high affinity for mu, delta, and kappa receptors. It is utilized in obesity research to study feeding behavior and reward pathways, as it reduces food intake and modulates mesolimbic dopamine in vivo. This compound is a valuable tool for investigating opioid-mediated signaling in both cellular and animal models.